| http://www.w3.org/ns/prov#value | - April 24, 2014 - 5:04am black wrote: What emerged in the aftermath was a practice where patent-holding pharmaceutical companies simply paid generic manufacturers not to challenge their patents, thus delaying the release of generic drugs for years.
|